Study of Visceral Fat in type2diabetic Patients and Its Relation to Microvascular Complications
Study of Visceral Fat in Type 2diabetic Patients and Its Relation to Microvascular Complications
1 other identifier
observational
100
1 country
1
Brief Summary
Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 26, 2023
CompletedFirst Posted
Study publicly available on registry
November 1, 2023
CompletedStudy Start
First participant enrolled
January 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 5, 2025
CompletedNovember 2, 2023
October 1, 2023
1 year
October 26, 2023
October 31, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
correlation between METS IR and visceral fat in type 2 diabetes
Study the cor relation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication
one year
Eligibility Criteria
Patients of T2DM, either newly diagnosed or previously diagnosed and on treatment with antidiabetic oral hypoglycemic agents or insulin and attending diabetes OPD or admitted to the Medicine Department, were taken as cases. Age- and gender-matched nondiabetic people admitted to the Medicine Department were taken as control subjects. Both these groups will be interviewed, examined, investigated, and included in the study.
You may qualify if:
- Age \> 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study
You may not qualify if:
- Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Mahmoud Soliman
Sohag, 00000, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
mahmoud soliman
Sohag University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ass.lecturer of internal medicine
Study Record Dates
First Submitted
October 26, 2023
First Posted
November 1, 2023
Study Start
January 5, 2024
Primary Completion
January 5, 2025
Study Completion
June 5, 2025
Last Updated
November 2, 2023
Record last verified: 2023-10